SCN1A and SCN2A polymorphisms are associated with response to valproic acid in Chinese epilepsy patients

Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies

Patrick Kwan, Alexis Arzimanoglou, Anne T. Berg et al. · Epilepsia · 2009 · 4.7K citations

Medicine, Neurology, Pharmacotherapy +17

Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy

Frank H. Yu, Massimo Mantegazza, Ruth E. Westenbroek et al. · Nature Neuroscience · 2006 · 1.2K citations

Medicine, Neurobiology, Neuroscience +17

The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial

Anthony G Marson, Asya M Al-Kharusi, Muna Alwaidh et al. · The Lancet · 2007 · 970 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Epilepsy: new advances

Solomon L. Moshé, Emilio Perucca, Philippe Ryvlin et al. · The Lancet · 2014 · 899 citations

Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome

Andreas Brunklaus, Rachael Ellis, Eleanor Reavey et al. · Brain · 2012 · 359 citations · Full text

Life Sciences, Genetics, Pediatrics +17